CEP55 and bladder transitional cell carcinoma: The combined results showed that there was higher expression of CEP55 mRNA in adrenocortical carcinoma (ACC), BLCA, BRCA, CESC, COAD, DLBC, GBM, HNSC, KIRC, LUAD, LUSC, ovarian serous cystadenocarcinoma (OV), PAAD, READ, SKCM, STAD, THYM, UCEC, and uterine carcinosarcoma (UCS), but lower levels in acute myeloid leukemia (LAML) (Figure 1C,D).